A new trading day began on Monday, with Immunic Inc (NASDAQ: IMUX) stock price up 7.27% from the previous day of trading, before settling in for the closing price of $1.10. IMUX’s price has ranged from $0.97 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 54.57%. With a float of $87.36 million, this company’s outstanding shares have now reached $90.08 million.
Let’s look at the performance matrix of the company that is accounted for 77 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunic Inc is 3.02%, while institutional ownership is 62.53%. The most recent insider transaction that took place on Nov 12 ’24, was worth 100,369. In this transaction Director of this company bought 87,300 shares at a rate of $1.15, taking the stock ownership to the 87,300 shares.
Immunic Inc (IMUX) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.48 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.50% during the next five years compared to 31.12% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Here are Immunic Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.73 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Immunic Inc (NASDAQ: IMUX) saw its 5-day average volume 0.76 million, a positive change from its year-to-date volume of 0.62 million. As of the previous 9 days, the stock’s Stochastic %D was 41.98%. Additionally, its Average True Range was 0.10.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 14.68%, which indicates a significant decrease from 59.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.34% in the past 14 days, which was lower than the 74.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3929, while its 200-day Moving Average is $1.3345. Nevertheless, the first resistance level for the watch stands at $1.2667 in the near term. At $1.3533, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4167. If the price goes on to break the first support level at $1.1167, it is likely to go to the next support level at $1.0533. Assuming the price breaks the second support level, the third support level stands at $0.9667.
Immunic Inc (NASDAQ: IMUX) Key Stats
With a market capitalization of 106.29 million, the company has a total of 90,079K Shares Outstanding. Currently, annual sales are 0 K while annual income is -93,610 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,370 K.
